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Introduction: Unlike cardiac arrest occurring out-of-hospital, the safety and eﬃcacy of
automated external deﬁbrillators (AED) in the hospital has not been assessed. This study
examined the conditions of AED use in hospital and the prognosis of these patients.
Methods and Results: We examined the condition and prognosis of 32 patients who were
given AED treatment while they were in an unconscious state in the hospital, between May
2004 and January 2007. During this period, AED was used only for patients, not for visitors or
hospital personnel.
Ventricular ﬁbrillation (VF) or ventricular tachycardia (VT) was observed in 7 patients, and
in the other 25 the initial rhythm of the patients did not require AED. Two patients survived
with the help of AED, but it did not deliver shock in two patients with VF and VT. There was
no signiﬁcant diﬀerence in vital prognosis due to the presence or absence of shock delivery in
the VF or VT patients.
Conclusion: The situation of AED use may be diﬀerent whether it is used in hospital or out-
of-hospital. This study suggests that using AED in the hospital may have limited eﬀect when
it is used for critically ill patients.
(J Arrhythmia 2008; 24: 26–32)
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Introduction
The safety and eﬃcacy of automated external
deﬁbrillators (AED) on patients with ventricular
ﬁbrillation (VF) in out-of-hospital settings has been
conﬁrmed.1–3) AED are also easy to use4) enabling
widespread access to the device which can be
operated by the ordinary citizens.5,6) Indeed, use of
AED is spreading in Japan today.7–9) We also
conﬁrmed its eﬃcacy at the Aichi Expo where it
was administered by ordinary citizens.10) Even
though the eﬃcacy of AED has been conﬁrmed,
there has been no data on their use in hospitals and
their eﬀect on patient prognosis.11) As a result, we
examined the in-hospital eﬃcacy of AED by
evaluating the prognosis of patients who were
administered AED.
Methods
Subjects
In May 2004 we placed 26 commercially available
AEDs, which cannot be switched to manual mode, in
the wards of our hospital. We held a monthly lecture
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on how to use AEDs to train the medical staﬀ,
including nurses, so that they could better operate
them. Manual deﬁbrillators were placed in the
circulatory ward, the intensive care unit and the
pediatric ward instead of AEDs. Therefore, AEDs
were only used in the general wards. In this study,
the users of AED were all medical staﬀs who did not
specialize in circulatory medicine. The AED was
used in about 20% by the nurses before arrival of the
doctor. We investigated all 32 patients to whom
deﬁbrillation pads of the AED were applied in an
unconscious state, from May 2004 to January 2007.
Cardiac arrest was observed in 29 patients (15
male and 14 female) whose average age was 69 13
years (average  standard deviation). Eighty six per
cent of the cardiac arrest patients had grave basal
disease such as terminal cancer.
Analysis
The AED we used was ‘‘Heart Start FR2,
M3860A’’ manufactured by Philips Medical. As
a condition for shock delivery, Heart Start FR2
requires more than ﬁve VF amplitudes of 200 mV
or higher during ﬁve seconds of electrocardiogram,
as well as twelve or more amplitudes which are
80 mV or higher each. It also delivers shock for
polymorphic ventricular tachycardia (VT) with a
heart rate of 150 beats per minute (bpm) or more and
monomorphic VT with a heart rate of 250 bpm or
more.
After AED use, we analyzed the electrocardio-
gram by retrieving the electrocardiogram data from
inside the Holter system using the Philips’ analysis
software ‘‘Event Review 3.5’’ from the data card
M3854A attached to the main body and manufac-
tured by Philips Medical System. We investigated
the patient’s basal disease, the condition of the
patient and the circumstances of AED use, relying on
the medical record of patients on whom AED was
used.
Regarding vital prognosis, patients who survived
by means of cardiopulmonary resuscitation were
included in the survival group; patients temporarily
experiencing a return of spontaneous circulation by
resuscitation but dying several hours later or several
days later were included in the subsequent death
group; and patients who died without successful
resuscitation were categorized in the instant death
group.
Patients who suﬀered cardiac arrest were divided
into two groups according to the time elapsed from
the beginning of unconsciousness to cardiopulmo-
nary resuscitation. Cardiac arrest patients who were
discovered instantly were categorized under the
group cardiac arrest witnessed. Patients who were
discovered unconscious by chance during rounds
were categorized under the group cardiac arrest not
witnessed.
The rate of occurrence was calculated with the
Fisher exact probability test.
Results
We categorized 32 patients in which AED was
used according to the heart rhythm at the time
unconsciousness was ﬁrst discovered. There were 3
non-cardiac-arrest patients who were unconscious-
ness, such as vagal reﬂection after urination, 22
patients with asystole or pulseless electrical activity
(PEA) (22=32 ¼ 69%), and 7 with VF or VT (5 VF
and 2 VT) (7=32 ¼ 22%) (Figure 1). Only 3 of the
asystole or PEA patients had heart disease (3=22 ¼
cause of unconsciousness
N=32
non-cardiac arrest 
N=3
cardiac arrest 
N=29
asystole or PEA
N=22
VF or VT
N=7
survival
N=1
group: C
subsequent
death
N=6
group: D
instant
death
N=15
group: E
survival
N=3
group: F
subsequent
death
N=3
group: G
instant
death
N=1
group: H
survival
N=2
group: A
subsequent
death
N=1
group: B Figure 1 The rhythm of the patients used
AED and outcome of the patients.
AED was used for non-cardiac arrest which was
not indication of use. AED was used to 22
asystole or PEA cases and seven VF or VT
cases.
PEA: pulseless electrical activity
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Table 1 List of patients.
Group Age Sex Pulse Presence of
shock delivery Outcome Basal disease Cause of syncope
A 88 F
sinus
bradycardia
 living hypertension vagal reﬂection
after urination
A 43 M sinus rhythm  living nothing insolation
B 58 F PVC  death after 6 hours multiple myeloma septic shock
C 72 F PEA  living with coma manic-depressive
psychosis
unknown
D 67 F asystole  death after 2 days cervical cancer unknown
D 81 F PEA  death after 3 hours otitis media pneumonia,
respiratory failure
D 71 F PEA  death after 10 days myelodysplastic
syndrome
unknown
D 68 F PEA  death after 10 days cerebral infarction bolus asphyxia
D 71 M asystole  death after 14 days kidney failure septic shock
D 67 M PEA  death after 2 days kidney failure unknown (post CABG)
E 74 M PEA  death hemorrhagic
colon polyp
unknown
E 77 M asystole  death interstitial pneumonia respiratory failure
E 83 F asystole  death scald of left leg unknown
E 82 M asystole  death hemorrhagic
gastric ulcer
unknown
(with OMI, heart failure)
E 88 M asystole  death kidney failure pneumonia,
respiratory failure
E 17 F asystole  death aplastic anemia cerebral hemorrhage
suspect
E 76 F asystole  death cataract unknown
E 55 M PEA  death feet necrosis hemorrhagic
duodenal ulcer
E 65 F asystole  death subarachnoid
hemorrhage
subarachnoid
hemorrhage
E 55 F asystole  death liver carcinoid perforative peritonitis
E 84 M PEA + death
multiple small
intestine ulcer
bolus asphyxia
E 63 M asystole  death liver cancer unknown
E 64 M asystole + death cerebral infarction
aspiration pneumonia
(with post CABG)
E 70 F asystole  death aplastic anemia septic shock
E 66 M asystole  death gastric ulcer unknown
(rupture of AAA suspect)
F 72 F VF + living liver cancer
acute myocardial
infarction
F 74 M VT (Tdp) + living delirium
drug induced Tdp
(with OMI)
F 66 F VT  living OMI heart failure
G 64 F VF  death after 1 hour gallbladder cancer respiratory failure
G 76 F VF + death after 6 days kidney failure heart failure
G 54 M VF + death after 14 hours
arteriosclerosis
obliterans
bowel necrosis
(post CABG)
H 73 M VF + death multiple myeloma pancreatitis
The details of group A-H of Table 1 are shown. Many patients had grave basal disease.
: Patients with epinephrine-induced VF or VT
OMI: old myocardial infarction, CABG: coronary artery bypass grafting, AAA: abdominal aortic aneurysm
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14%). Five patients with VF or VT had heart disease
(5=7 ¼ 71%) (Table 1).
Shock delivery
AED did not deliver shock to all the patients with
non-cardiac arrest and asystole or PEA. AED did
deliver shock in ﬁve patients with VF or VT (4 VF
and 1 Torsade de pointes). One VF (Figure 2) and 1
monomorphic VT patient were not delivered shock.
When discovered unconscious, 6 out of 22 patients
with asystole or PEA developed VF or VT after
intravenous injection of epinephrine during resusci-
tation (2 VF and 4 monomorphic VT). Two patients
with epinephrine-induced VF were delivered shock.
However, 4 patients with epinephrine-induced mon-
omorphic VT did not receive shock. All 5 patients
with monomorphic VT, including the epinephrine-
induced ones, were not delivered shock because their
heart rates were too slow to fulﬁll the diagnostic
criteria for Heart Start FR2 (Figure 3).
Vital prognosis after AED use
Two out of 3 patients with non-cardiac arrest
survived. The remaining 1 patient died from septic
shock a few hours later.
One patient among those with asystole or PEA
survived, 6 died subsequently and 15 died instantly.
The sole survivor from asystole or PEA survived in a
comatose state.
Among those with VF or VT, 3 patients survived,
3 died subsequently and 1 died instantly. In the
prognoses of those VF or VT patients in which
AED did not deﬁbrillate, 1 monomorphic VT patient
survived and 1 VF patient died subsequently. As for
the prognosis of those VF or VT patients in which
AED did deﬁbrillate, 2 (1 VF caused by acute
myocardial infarction and 1 Torsade de pointes
caused by proarrhythmia with old myocardial in-
farction) survived, 2 VF patients died subsequently
and 1 VF patient died instantly (Table 2).
We examined the 7 VF and VT patients for the
relationship between the presence or absence of shock
delivery and the prognosis for survival, subsequent
death or instant death, but failed to ﬁnd any signiﬁcant
diﬀerence. In 29 cardiac arrest patients, we tested for
a relationship between the presence or absence of
shock delivery (including epinephrine induced VF
or VT) and the prognosis for survival, subsequent
death or instant death. We found no signiﬁcant
diﬀerence between them (Table 3).
2 div/mV, 5 div/sec
New use
Pads on
Start of ECG
Pads marginal
Shock advised
No shock advised
Monitoring
Disarmed
Figure 2 Ventricular ﬁbrillation in which AED did not deliver shock.
The electrocardiogram indicated that the patient had VF but was not delivered shock since the diagnostic criteria for AED was not fulﬁlled.
: No shock delivered
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Prognosis of VF or VT for contributing factors
Four patients had a cardiogenic form of VF or VT
such as exacerbation of heart failure and myocardial
infarction. Two had VF or VT triggered by acidosis.
The contributing factor was unknown for 1 (VF).
We had 3 surviving patients (1 VF and 2 VT) and 1
subsequent death (VF) among those with cardiogenic
VF or VT. All VF or VT patients that were triggered
by acidosis died subsequently (2 VF). Thus, we did
not ﬁnd any signiﬁcant diﬀerence in the survival
rate for contributing factors (Table 3). Further, 2
epinephrine-induced VF patients received deﬁbrilla-
tion but died instantly. Of the 4 epinephrine-induced
VT patients, 2 died subsequently and 2 instantly.
Survival rate from onset of cardiac arrest to start
of cardiopulmonary resuscitation
The number of cardiac arrest witnessed patients
were 22 (22=29 ¼ 76%), while the total number of
cardiac arrest patients were 29. The number of
cardiac arrest not witnessed patients were 7 (7=29 ¼
24%). Among both groups — cardiac arrest wit-
nessed and cardiac arrest not witnessed — there
were only 2 patients who survived in each group.
Thus, we did not ﬁnd any signiﬁcant diﬀerence in
the survival rate for either group (Table 4).
In the group of cardiac arrests witnessed, there
were 6 patients with VF or VT, while in the group of
cardiac arrests not witnessed, there was 1 with VF or
VT. We failed to ﬁnd a signiﬁcant diﬀerence in the
VF or VT occurrence rate in either group (Table 4).
In 6 patients with VF or VT from the cardiac arrest
witnessed group, 2 survived (2=6 ¼ 33%), and
among the 16 patients with asystole or PEA from
the same group, none survived. We did not ﬁnd a
signiﬁcant diﬀerence in the survival rate in either the
VF or VT, or asystole or PEA patients (Table 3).
There were 6 patients with VF or VT witnessed.
AED delivered shock to 4 of them and 1 survived.
However, in 2 of the 6 pateints, AED did not deliver
shock and 1 survived (monomorphic VT). We did
not detect any signiﬁcant diﬀerence in the survival
rate among the VF or VT witnessed patients, due to
the presence or absence of shock delivery (Table 3).
Discussion
Regarding vital prognosis
Two out of the 32 patients who were treated with
AED survived with the help of deﬁbrillation. Adding
the subsequent death to the surviving patients pushed
the total percentage up to 13% (4 out of 32). In out-
of-hospital cardiac arrest cases, it is said that whether
the heart rhythm is VF or VT at the time when
emergency medical assistants arrive on the scene is
the most important factor in determining the prog-
nosis.12) The reason why we have not been able to
save many patients is that most of the patients
experiencing cardiac arrest in the hospital (excepting
the circulatory ward) had asystole or PEA, and not
VF or VT. According to the report from King
County (Washington),13) the cases that were wit-
nessed by the bystanders were 6,590 among 12,591
cardiac arrest with cardiac etiology cases. The cases
Table 2 Condition of shock delivery.
Survival Subsequentdeath
Instant
death
Non-cardiac arrest n ¼ 3 2/0 1/0 0/0
Asystole or PEA n ¼ 22 1/0 6/0 13/2y
VF or VT n ¼ 7 1/2 1/2 0/1
Shock was delivered to ﬁve out of seven VF or VT patients
and two out of six epinephrine-induced VF or VT patients
in which asystole or PEA was ﬁrst recorded.
The number indicates non-delivery/delivery of shock
y: Epinephrine-induced VF or VT
No shock advised
Monitoring
Disarmed
Figure 3 Ventricular tachycardia patient in which AED did not deliver shock.
Monomorphic VT patient with a heart rate of 160 beats per minute did not receive shock since the heart rate was too slow to fulﬁll the
diagnostic criteria for Heart Start FR2.
: no shock delivered
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in which the initial rhythm was VF were 4,190 those
witnessed. VF accounted for 64% of cardiogenic
cardiac arrests witnessed out of hospital. In our
hospital, 6 out of 22 cardiac arrests witnessed had
an initial rhythm of VF or VT, and there was a
signiﬁcantly small ratio of VF or VT cases in our
hospital (except the circulatory ward) compared to
the report from King County (p ¼ 0:0006). How-
ever, since we have fewer mortalities in Japan due to
ischemic heart disease, it is likely we have fewer
patients with VF or VT compared to Europe and the
US.14) In any case, the situation of AED use may be
diﬀerent whether it is used in or out of hospital. It
was thought that a reason for the abundance of
asystole or PEA was related to the high incidence of
basal disease for in hospital cardiac arrest. Because
irreversible basal disease was grave, in most cases, it
was thought that it presented asystole or PEA. In our
hospital, 16 out of 22 cardiac arrests witnessed had
asystole or PEA and none of them survived. Thus,
the prognosis for asystole or PEA patients was poor.
We compared the survival rates from the patients
with asystole or PEA in our hospital and the one in
the King County report but we did not ﬁnd a
signiﬁcant diﬀerence (p ¼ 0:6199). Although in-
hospital asystole or PEA patients underwent instant
resuscitation, the survival rate was the same as those
that occurred out-of-hospital.
Outcome of VF or VT patients
VF or VT resulted in AED shock delivery.
However, 3 out of 5 VF or VT patients that received
shock died. Because basal disease was grave, it was
considered that they died from basal disease. In the
VF or VT patients for who the AED did not operate,
a few presented temporary spontaneous sinus rhythm
only through cardiopulmonary resuscitation (chest
compressions, etc.). Epinephrine induced VT was
transient, and the rhythm presented asystole imme-
diately. We did not ﬁnd a signiﬁcant diﬀerence
between the ones that received deﬁbrillation and the
ones that did not. The presence or absence of
deﬁbrillation did not have any eﬀect on the vital
prognosis. We consider that this result stemmed
from the fact that VF or VT was triggered by
irreversible clinical conditions such as acidosis. We
reasoned that even critically ill patients with VF or
VT in terminal stage, who received deﬁbrillation,
died because the primary disease was not cured. We
did not ﬁnd a signiﬁcant diﬀerence between survival
rates of cardiogenic VF or VT and those of acidosis
VF or VT. However, we consider that the more cases
Table 3 Vital prognosis of patients in whom AED was used.
survival subsequent death
or instant death p value
VF or VT n ¼ 7 Presence of shock delivery n ¼ 5 2 3 p > 0:9999
Absence of shock delivery n ¼ 2 1 1
Cardiac arrest n ¼ 29 Presence of shock delivery n ¼ 7
y 2 5
p ¼ 0:2381
Absence of shock delivery n ¼ 22 2 20
VF or VT triggeredyy Cardiogenic VF or VT n ¼ 4 3 1 p ¼ 0:4000
Acidosis VF n ¼ 2 0 2
Cardiac arrest witnessed n ¼ 22 VF or VT n ¼ 6 2 4 p ¼ 0:0649
Asystole or PEA n ¼ 16 0 16
VF or VT witnessed n ¼ 6 Presence of shock delivery n ¼ 4 1 3 p > 0:9999
Absence of shock delivery n ¼ 2 1 1
We did not ﬁnd any signiﬁcant diﬀerences among vital prognosis for VF or VT, cardiac arrest and VF or VT witnessed
patients in the presence or absence of shock delivery.
y: Including deﬁbrillation for epinephrine-induced VF or VT patients.
yy: Trigger of 1 patient was unknown.
Table 4 Comparison of 29 cardiac arrest patients according
to witnessed or not witnessed.
Cardiac arrest
n ¼ 29 Witnessed
Not
witnessed p value
VF or VT 6 1
p ¼ 0:6457
Asystole or PEA 16 6
Survival 2 2
p ¼ 0:2381
Subsequent
or instant death 20 5
We did not ﬁnd any signiﬁcant diﬀerences between the
vital prognosis between witnessed and non witnessed
cardiac arrest patients, nor did we ﬁnd any signiﬁcant
diﬀerences in rhythm when the patients were discovered
between witnessed and not witnessed cases cardiac arrest
patients.
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we have the worse the prognosis will be for acidosis
VF or VT.15)
Possible cases of cardiac arrest not witnessed
For 7 patients in whom cardiac arrest was not
witnessed, the rhythm was unknown at the onset of
unconsciousness. Two of the 7 patients took psycho-
trophic drugs orally and had PEA when found
unconscious; but it is also possible that they had
Torsade de pointes from QT prolongation, which is a
side-eﬀect caused by psychotrophic drugs, when they
became unconscious.16) It is considered that at the
onset of unconsciousness it was due to VF or VT but
that as time passed, when the patient was discovered,
conditions had changed to asystole or PEA.
Conditions for shock delivery
Because AED did not deliver shock in all the
patients with non-cardiac arrest and asystole or PEA,
AED was safe. In this study, since all monomorphic
VT cases did not fulﬁll the diagnostic criteria for
Heart Start FR2, it did not deliver shock in these
cases. Each AED model has diﬀerent criteria for
shock delivery. When VT is detected, Cardiolife
AED-9200 delivers shock at a heart rate of more
than 180 bpm, while LIFEPAK LP 500B and
LIFEPAK CR Plus deliver at a heart rate of more
than 120 bpm (also, at QRS interval of 160 milli-
seconds and no apparent preceding P wave). There-
fore, we consider that deﬁbrillation conditions diﬀer
depending on the model used.
Limitations
In this study AED was used in hospital, but it was
not used for the patients with heart disease nor
relatively healthy people such as visitors or hospital
personnel. The AED is reported to be beneﬁcial
when it is used in a public space. We believe that the
results of this study may change if it were used on
other population.
Conclusions
We investigated all 32 patients who were applied
AED deﬁbrillation pads in an unconscious state in
our hospital. VF or VT was observed in 7 patients and
in the other 25 the initial rhythm of the patients did
not require AED. Spontaneous rhythm was recovered
in 4 patients by deﬁbrillation and 2 survived.
Although the eﬃcacy of AED on patients with VF
in out-of-hospital settings has been conﬁrmed, our
research indicated the possibility that the placement
of AED in hospital (excluding the circulatory ward)
may have limited eﬃcacy for critically ill patients.
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